Read + Share
Exterkate L, Wegelin O, Barentsz JO, van der Leest MG, et al. Incidence of significant prostate cancer after negative MRI and systematic biopsy
in the FUTURE trial. BJU Int 2022 Aug 22. doi: 10.1111/bju.15876.
PMID: 35993590
|
 |
|
Exterkate L, Wegelin O, Barentsz JO, van der Leest MG, et al. Incidence of significant prostate cancer after negative MRI and systematic biopsy
in the FUTURE trial. BJU Int 2022 Aug 22. doi: 10.1111/bju.15876.
PMID: 35993590
|
|
|
|